Goldman Backs China Bulls With Its 50 ‘Common Prosperity’ Stocks
Goldman Lists 50 China Stocks to Benefit From Common Prosperity
(Bloomberg) -- Goldman Sachs Group Inc. has spotlighted 50 China stocks that stand to benefit from President Xi Jinping’s “common prosperity” campaign, bolstering the view that Beijing’s regulatory shakeup is also bringing opportunities.
Companies connected to themes such as manufacturing upgrading, green energy, state-owned enterprise reforms and mass consumption can benefit from Xi’s ambitions, strategists including Kinger Lau said in note dated Monday.
While Chinese stocks have taken a battering this year since peaking in February, prices are ticking back up this month amid a reassessment of valuations and the longer-term impact of policy shifts. HSBC Holdings Plc analysts upgraded their call on Chinese stocks to overweight this week, adding to upbeat assessments of the outlook from BlackRock Inc., UBS Group AG and Fidelity International.
Goldman’s model portfolio includes communication-equipment maker Xiaomi Corp., LONGi Green Energy Technology Co. and sportswear producer Li Ning Co. The 50 companies have a combined market capitalization of about $1 trillion, and could grow profits at a compound annual growth rate of 27% in the next two years, the strategists said.
“We believe ‘Common Prosperity’ is more than just about redistribution but an overarching development plan led by the Communist Party that could reshape China’s future growth trajectory in the years to come,” they said.
Stocks in Goldman’s “Common Prosperity” model portfolio | |||
---|---|---|---|
Xiaomi | China Tourism Group Duty Free | GigaDevice Semiconductor | Han’s Laser Technology |
LONGi Green Energy | Luxshare Precision | Wuxi Lead | Chinasoft International |
Li Ning | Sungrow Power Supply | Inovance Technology | Thunder Software Tech |
Gree Electric | Hengrui Medicine | CSPC Pharma | Senior Technology Material |
Trip.com | Muyuan Foods | Sanan Optoelectronics | Lepu Medical Technology |
Anta Sports | Will Semiconductor | Xinyi Solar | Hua Hong Semiconductor |
Xinyi Solar | Yunnan Energy New Material | Wingtech Technology | Feihe |
Fosun Pharma | Sanhua Intelligent Controls | Maxscend Microelectronics | Biological Engineering |
Chint Electrics | Jinjiang International Hotels | Putailai New Energy | Ecovacs Robotics |
Roborock Technology | Juewei Food | Jason Furniture | Flat Glass |
Hansoh Pharma | Songcheng Performance | Tongcheng-Elong | Goodix Technology |
Betta Pharma | By-health | Shennan Circuits | Friendess Electronic Tech |
Robam | Dingli Machinery | Zhejiang Supor |
Still, luxury consumption, “soft” tech with high data intensity, and socially-important sectors may see continuing regulation headwinds, according to Goldman.
HSBC said “the baby is being thrown out with the bathwater” by pessimists on China. It sees value in real estate, industrials, healthcare and some banks.
UBS sees tighter regulation as being priced in already and BlackRock thinks there is “room for tactical upside.”
Read more |
---|
HSBC Upgrades China Stocks to Overweight in Rebuff to Bears |
BlackRock, UBS Turning Into China Stock Bulls as Fears Ease |
Fidelity Sees Good Risk-Reward in Stocks: What to Watch in China |
©2021 Bloomberg L.P.